251 related articles for article (PubMed ID: 17437420)
1. Increased serum high mobility group box-1 level in Churg-Strauss syndrome.
Taira T; Matsuyama W; Mitsuyama H; Kawahara KI; Higashimoto I; Maruyama I; Osame M; Arimura K
Clin Exp Immunol; 2007 May; 148(2):241-7. PubMed ID: 17437420
[TBL] [Abstract][Full Text] [Related]
2. Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome.
Guilpain P; Auclair JF; Tamby MC; Servettaz A; Mahr A; Weill B; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Jun; 1107():392-9. PubMed ID: 17804567
[TBL] [Abstract][Full Text] [Related]
3. Sputum eosinophilia in Churg-Strauss syndrome.
Meziane H; Maakel ML; Vachier I; Bousquet J; Chanez P
Respir Med; 2001 Oct; 95(10):799-801. PubMed ID: 11601744
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome.
Jakiela B; Szczeklik W; Sokolowska B; Mastalerz L; Sanak M; Plutecka H; Szczeklik A
Rheumatology (Oxford); 2009 Oct; 48(10):1202-7. PubMed ID: 19643727
[TBL] [Abstract][Full Text] [Related]
5. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
[TBL] [Abstract][Full Text] [Related]
6. High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study.
Gaïni S; Pedersen SS; Koldkjaer OG; Pedersen C; Møller HJ
Crit Care; 2007; 11(2):R32. PubMed ID: 17346334
[TBL] [Abstract][Full Text] [Related]
7. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.
Polzer K; Karonitsch T; Neumann T; Eger G; Haberler C; Soleiman A; Hellmich B; Csernok E; Distler J; Manger B; Redlich K; Schett G; Zwerina J
Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958
[TBL] [Abstract][Full Text] [Related]
8. Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome.
Saito H; Tsurikisawa N; Tsuburai T; Akiyama K
Int Arch Allergy Immunol; 2008; 146 Suppl 1():73-6. PubMed ID: 18504411
[TBL] [Abstract][Full Text] [Related]
9. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.
Kim S; Marigowda G; Oren E; Israel E; Wechsler ME
J Allergy Clin Immunol; 2010 Jun; 125(6):1336-43. PubMed ID: 20513524
[TBL] [Abstract][Full Text] [Related]
10. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ
Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
[TBL] [Abstract][Full Text] [Related]
11. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis.
Yasuda T; Ueda T; Takeyama Y; Shinzeki M; Sawa H; Nakajima T; Ajiki T; Fujino Y; Suzuki Y; Kuroda Y
Pancreas; 2006 Nov; 33(4):359-63. PubMed ID: 17079940
[TBL] [Abstract][Full Text] [Related]
12. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation.
Malm-Erjefält M; Greiff L; Ankerst J; Andersson M; Wallengren J; Cardell LO; Rak S; Persson CG; Erjefält JS
Clin Exp Allergy; 2005 Oct; 35(10):1334-40. PubMed ID: 16238793
[TBL] [Abstract][Full Text] [Related]
13. Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome.
Kawakami T; Soma Y; Kawasaki K; Kawase A; Mizoguchi M
Arch Dermatol; 2005 Jul; 141(7):873-8. PubMed ID: 16027304
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of TRAIL receptor 3 on eosinophils in Churg-Strauss syndrome.
Mitsuyama H; Matsuyama W; Watanabe M; Shirahama Y; Higashimoto I; Wada T; Osame M; Arimura K
Arthritis Rheum; 2007 Feb; 56(2):662-73. PubMed ID: 17265502
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.
Hellmich B; Csernok E; Gross WL
Ann N Y Acad Sci; 2005 Jun; 1051():121-31. PubMed ID: 16126951
[TBL] [Abstract][Full Text] [Related]
16. Churg-Strauss syndrome.
Keogh KA; Specks U
Semin Respir Crit Care Med; 2006 Apr; 27(2):148-57. PubMed ID: 16612766
[TBL] [Abstract][Full Text] [Related]
17. [Churg-Strauss syndrome. Personal caseload and review of the literature].
Manganelli P; Troise Rioda W; Buzio C; Pavesi G; Gemignani F
Minerva Med; 1994; 85(7-8):387-93. PubMed ID: 7936357
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features of allergic granulomatosis and angiitis (Churg-Strauss syndrome). Association with asthma symptoms].
Higashimoto I; Umehara F; Koreeda Y; Watanabe T; Kawabata M; Arimura K; Osame M
Arerugi; 1996 Nov; 45(11):1154-60. PubMed ID: 8990526
[TBL] [Abstract][Full Text] [Related]
19. Churg-Strauss syndrome occurring 30 years after the onset of ulcerative colitis.
Prekates AA; Orfanos SE; Routsi CJ; Ch Pantelidaki A; Roussos CS
Respir Care; 2002 Feb; 47(2):167-70. PubMed ID: 11812273
[TBL] [Abstract][Full Text] [Related]
20. Increased serum HMGB1 is related to the severity of coronary artery stenosis.
Hu X; Jiang H; Bai Q; Zhou X; Xu C; Lu Z; Cui B; Wen H
Clin Chim Acta; 2009 Aug; 406(1-2):139-42. PubMed ID: 19545550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]